This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Mathieu Ribault
Introduction
Mathieu Ribault is a notable inventor based in Lyon, France. He has made significant contributions to the field of medical technology, particularly in the area of ultrasound treatment. His innovative approach has led to advancements that enhance the effectiveness of focused ultrasound therapies.
Latest Patents
Ribault holds a patent for a groundbreaking invention titled "Frequency adjustment in high intensity focused ultrasound treatment apparatus." This invention concerns an apparatus designed for treating biological samples by emitting focused high-intensity ultrasounds towards a focal point. The apparatus is characterized by its means of emitting wideband focused ultrasounds. It enables the adjustment of the focused ultrasound frequency based on various factors, including target attenuation, tissue thickness, temperature evolution, and lesion displacement during emission. This innovation represents a significant step forward in the precision of ultrasound treatments.
Career Highlights
Throughout his career, Mathieu Ribault has demonstrated a commitment to advancing medical technology. His work has not only contributed to the development of new treatment methods but has also paved the way for further research in the field of ultrasound applications. His patent reflects his dedication to improving patient outcomes through innovative solutions.
Collaborations
Ribault has collaborated with esteemed colleagues in his field, including Jean-Yves Chapelon and Emmanuel Blanc. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.
Conclusion
Mathieu Ribault's contributions to the field of ultrasound treatment exemplify the importance of innovation in medical technology. His patent and collaborative efforts highlight the potential for advancements that can significantly improve therapeutic outcomes.